Infant formula shortage: FDA chief faces fury for slow response to problem

26 May, 2022
Share with a friend

Infant formula shortage: FDA chief faces fury for slow response to problem

The head of the Food and Drug Administration faced bipartisan anger from lawmakers in the House of Representatives on Wednesday over months of delays in investigating problems at the nation's largest infant formula plant that have led to persistent shortages.


Food and Drug Administration Commissioner Robert Califf has laid down a series of setbacks in Congressional testimony that have slowed his agency's response, including a COVID-19 outbreak at the plant and a whistleblower complaint that failed to reach FDA leadership because it was apparently lost in the mail. .


Califf testified before a House subcommittee investigating the shortage, which escalated into a major political debate and forced the United States to begin airlifting products from Europe.


Share with a friend